These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11559702)

  • 1. Proteasome inhibition in glyoxal-treated fibroblasts and resistance of glycated glucose-6-phosphate dehydrogenase to 20 S proteasome degradation in vitro.
    Bulteau AL; Verbeke P; Petropoulos I; Chaffotte AF; Friguet B
    J Biol Chem; 2001 Dec; 276(49):45662-8. PubMed ID: 11559702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein.
    Friguet B; Szweda LI
    FEBS Lett; 1997 Mar; 405(1):21-5. PubMed ID: 9094417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome-dependent degradation of oxidized proteins in MRC-5 fibroblasts.
    Sitte N; Merker K; Grune T
    FEBS Lett; 1998 Dec; 440(3):399-402. PubMed ID: 9872410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glyoxal-derived advanced glycation end-products, N
    Kang J; Jeong YJ; Ha SK; Lee HH; Lee KW
    Mol Biol Rep; 2023 Mar; 50(3):2511-2520. PubMed ID: 36609749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear proteasome activation and degradation of carboxymethylated histones in human keratinocytes following glyoxal treatment.
    Cervantes-Laurean D; Roberts MJ; Jacobson EL; Jacobson MK
    Free Radic Biol Med; 2005 Mar; 38(6):786-95. PubMed ID: 15721989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin inhibition of proteasome activity in intact cells.
    Hamel FG; Bennett RG; Harmon KS; Duckworth WC
    Biochem Biophys Res Commun; 1997 May; 234(3):671-4. PubMed ID: 9175773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of hypochlorite-damaged glucose-6-phosphate dehydrogenase by the 20S proteasome.
    Ullrich O; Reinheckel T; Sitte N; Grune T
    Free Radic Biol Med; 1999 Sep; 27(5-6):487-92. PubMed ID: 10490267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of the chymotrypsin-like activity of proteasome based on di- and tri-peptidyl alpha-keto aldehydes (glyoxals).
    Lynas JF; Harriott P; Healy A; McKervey MA; Walker B
    Bioorg Med Chem Lett; 1998 Feb; 8(4):373-8. PubMed ID: 9871688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence.
    Ahmed N; Thornalley PJ
    Biochem J; 2002 May; 364(Pt 1):15-24. PubMed ID: 11988071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of glucose-6-phosphate dehydrogenase modified by 4-hydroxy-2-nonenal and metal-catalyzed oxidation to proteolysis by the multicatalytic protease.
    Friguet B; Szweda LI; Stadtman ER
    Arch Biochem Biophys; 1994 May; 311(1):168-73. PubMed ID: 8185314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasomal degradation of glycated proteins depends on substrate unfolding: Preferred degradation of moderately modified myoglobin.
    Raupbach J; Ott C; Koenig J; Grune T
    Free Radic Biol Med; 2020 May; 152():516-524. PubMed ID: 31760091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glyoxal-induced formation of advanced glycation end-products in type 1 collagen decreases both its strength and flexibility in vitro.
    Kitamura KI; Hirayama J; Tabuchi Y; Minami T; Matsubara H; Hattori A; Suzuki N
    J Diabetes Investig; 2021 Sep; 12(9):1555-1559. PubMed ID: 33605082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P'-extended alpha-ketoamide inhibitors of proteasome.
    Chatterjee S; Dunn D; Mallya S; Ator MA
    Bioorg Med Chem Lett; 1999 Sep; 9(17):2603-6. PubMed ID: 10498217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: insights into specificity and potency.
    Kim KB; Myung J; Sin N; Crews CM
    Bioorg Med Chem Lett; 1999 Dec; 9(23):3335-40. PubMed ID: 10612595
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Kinoshita S; Mera K; Ichikawa H; Shimasaki S; Nagai M; Taga Y; Iijima K; Hattori S; Fujiwara Y; Shirakawa JI; Nagai R
    Oxid Med Cell Longev; 2019; 2019():9073451. PubMed ID: 31583049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated formation of N epsilon-(carboxymethyl) lysine, an advanced glycation end product, by glyoxal and 3-deoxyglucosone in cultured rat sensory neurons.
    Niwa H; Takeda A; Wakai M; Miyata T; Yasuda Y; Mitsuma T; Kurokawa K; Sobue G
    Biochem Biophys Res Commun; 1998 Jul; 248(1):93-7. PubMed ID: 9675092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins.
    Reddy S; Bichler J; Wells-Knecht KJ; Thorpe SR; Baynes JW
    Biochemistry; 1995 Aug; 34(34):10872-8. PubMed ID: 7662668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of heat shock proteins and the proteasome system by casein-N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)lysine in Caco-2 cells.
    Schmid K; Haslbeck M; Buchner J; Somoza V
    Ann N Y Acad Sci; 2008 Apr; 1126():257-61. PubMed ID: 18448826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diet-derived advanced glycation end products or lipofuscin disrupts proteostasis and reduces life span in Drosophila melanogaster.
    Tsakiri EN; Iliaki KK; Höhn A; Grimm S; Papassideri IS; Grune T; Trougakos IP
    Free Radic Biol Med; 2013 Dec; 65():1155-1163. PubMed ID: 23999505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease.
    Friguet B; Stadtman ER; Szweda LI
    J Biol Chem; 1994 Aug; 269(34):21639-43. PubMed ID: 8063806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.